PD-L1 Boosts MET Phosphorylation, Promotes Osimertinib Resistance
In a groundbreaking study, researchers have elucidated the complex interplay between PD-L1 and c-MET, revealing significant insights that could alter ...
Tag: EGFR mutation targeted therapy
Aumolertinib Combined with Chemotherapy Enhances Progression-Free Survival in NSCLC Patients Harboring EGFR and Tumor Suppressor Gene Alterations: Findings from the ACROSS 2 Phase III Trial
Groundbreaking Phase III Trial Demonstrates Superior Efficacy of Aumolertinib Plus Chemotherapy in Advanced EGFR-Mutant NSCLC In a pivotal advancement for ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!